{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiebjqlmgrwd4sfh7cso55mhujkcpomo7pcdtqib3aaxe2neyu3wje",
    "uri": "at://did:plc:lczpo4ibci7od4ykrkratbdv/app.bsky.feed.post/3mh4tlgw7j7f2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib3gb2dwgxjwstf4l7m44sjnb74nhqjbvyzsm6tk7ap56ppwk4uie"
    },
    "mimeType": "image/jpeg",
    "size": 89724
  },
  "path": "/2026/03/first-puberty-blockers-now-hormones-englands-nhs-bans-more-gender-affirming-drugs/",
  "publishedAt": "2026-03-15T19:00:00.000Z",
  "site": "https://www.lgbtqnation.com",
  "tags": [
    "Law & Policy",
    "Cass Review",
    "gender-affirming care",
    "Hormone Replacement Therapy",
    "National Health Service",
    "puberty blockers",
    "Transgender Youth",
    "UK"
  ],
  "textContent": "A Cass Review follow-up claims the \"evidence does not support\" the use of estrogen and testosterone for trans youth.",
  "title": "First puberty blockers, now hormones: England’s NHS bans more gender-affirming drugs"
}